Image

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Study on Lunsekimig for COPD patients with eosinophilic phenotype.

Recruiting
40-80 years
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study aims to test a new medicine called lunsekimig for people with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease making it hard to breathe. Some people with COPD have higher levels of a type of white blood cell called eosinophils, which this study focuses on. Participants will be given lunsekimig or a placebo (a harmless pill) through a shot for 48 weeks. A placebo is used to compare and see if the new medicine works better.

  • The study lasts about 60 weeks including screening, treatment, and follow-up periods.
  • Participants should be between 40 to 80 years old and have had COPD for at least 1 year.
  • Certain health conditions or therapies might prevent participation, so check eligibility carefully.
Print
Study details
    Chronic Obstructive Pulmonary Disease

NCT07190209

Sanofi

12 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.